Maravai Q4 revenue $49.9M, net loss $63M; guides 2026 revenue $200-210M

MARAVAI LIFESCIENCES HOLDINGS, INC.

2025-FY EPS reported -$0.90 revenue$185,743,000

Q4 revenue $49.9M, net loss $(63.0)M, positive Adj EBITDA $0.5M (non-GAAP).
Full year 2025 revenue $185.7M, net loss $(230.8)M, Adj EBITDA $(31.2)M.
Introduces 2026 revenue guidance $200M-$210M and Adj EBITDA guidance $18M-$20M.
CEO cites strong execution, exceeding revenue expectations, returning to positive Adj EBITDA.
Organizational restructuring and operating cost reduction ahead of plan.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.